Psychiatr. pro Praxi, 2006; 5: 229-234

USING OF LAMOTRIGINE IN THE TREATMENT OF PSYCHICAL DISORDERS

doc. MUDr. Ján Praško CSc1,3,2,4, MUDr. Erik Herman5,7,6, MUDr. Pavel Doubek5, doc. MUDr. Jiří Hovorka CSc6,8, MUDr. Hana Prašková1
1 Psychiatrické centrum Praha, 3. LF UK, Praha
2 Centrum neuropsychiatrických studií, Praha
3 Psychiatrická klinika FN a LF UP, Olomouc
4 3. LF UK, Praha
5 Psychiatrická klinika 1. LF UK a VFN Praha
6 Neurologické oddělení, neuropsychiatrické a epileptologické centrum, Nemocnice Na Františku s poliklinikou, Praha
7 Psychiatrická ambulance, Praha
8 Neurochirurgická klinika 1. LF UK, Praha

Lamotrigine is an anticonvulsant drug with good efficacy and safety in the treatment of epilepsy. There is now substantial evidence that lamotrigine is also useful in treating bipolar disorder, resistant depression, rapid cycling bipolar disorder and in the maintenance phase or profylaxis of bipolar disorder. Recent reports suggesting that lamotrigine can be also an effective possibility for treatment in borderline personality disorder, a common comorbid personality disorder in bipolar patients, have possible role in reducing chronic pain and treating schizoaffective disorder.

Keywords: lamotrigine, bipolar disorder, bordeline personality disorder, schizoafective disorder, resistant depression

Published: December 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Praško J, Herman E, Doubek P, Hovorka J, Prašková H. USING OF LAMOTRIGINE IN THE TREATMENT OF PSYCHICAL DISORDERS. Psychiatr. praxi. 2006;7(5):229-234.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Anand A, Oren DA, Berman RM. Lamotrigine treatment of lithium failure in outpatient mania: a double-blind, placebo-controlled trial. In: Soares JC, Gerson S (eds): Abstract Book, Third International Bipolar Conference. Pittsburgh, Munksgaard 1999; 23.
    2. Ascher J Barnett S, Batey S. Safety and tolerability of lamotrigine in controlled mood disorder trials. Presentation at the 154th annual meeting of the American Psychiatric Association, New Orleans, LA, May 5-10, 2001.
    3. Asnis GM, Kohn SR, Henderson M, Brown N. SSSRs versus non-SSRIs in post-traumatic stress disorder: An update with recommendations. Drugs 2004; 64: 383-404. Go to original source... Go to PubMed...
    4. Ayala G, Matsumoto H, Gumnit R. Excitability changes and inhibitory mechanisms in neurocortical neurons during seizures. J Neurophysiol 1970; 33: 73-85. Go to original source... Go to PubMed...
    5. Besag F, Ng G, Pool F. Successful re-introduction of lamotrigine after initial rash. Seizure 2000; 9: 282-286. Go to original source... Go to PubMed...
    6. Bowden CL. Novel treatments for bipolar disorder. Expert Opin Investig Drugs2001; 10: 661-671. Go to original source... Go to PubMed...
    7. Bowden CL, Calabrese JR, Sachs G et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392-400. Go to original source... Go to PubMed...
    8. Calabrese JR, Woyshville MJ, Kimmel SE. Rapport DJ. Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol 1993; 13: 280-283. Go to original source... Go to PubMed...
    9. Calabrese JR, Bowden CL, McElroy SL, Cookson J, Anderson J, Keck PE Jr, Rhodes L, Bolden-Watson C, Zhou J, Ascher JA. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry 1999; 156: 1019-1023. Go to original source... Go to PubMed...
    10. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monagham E, Rudd GD (Lamictal 602 Study Group). A double - blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999; 60: 79-88. Go to original source... Go to PubMed...
    11. Calabrese J, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monagham ET (Lamictal 614 Study Group). A double-blind, placebocontrolled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000; 61: 841-850. Go to original source... Go to PubMed...
    12. Calabrese JR, Shelton MD, Bowden CL, Rapport DJ, Suppes T, Shirley ER, Kimmel SE, Caban SJ. Bipolar rapid cycling: focus on depression as its hallmarks. J Clin Psychiatry 2001; 62 (suppl 14): 34-41.
    13. Calabrese JR, Bowden CL, Sachs G et al. for the Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar disorder. J Clin Psychiatry 2003; 64: 1013-1024. Go to original source... Go to PubMed...
    14. Catterall W. Common modes of drug action on Na+ channels: local anaestethics, antiarrythmics and anticonvulsants. Trends Pharmacol Sci 1987; 8: 57-65. Go to original source...
    15. Cohn JB, Collins G, Ashbrook E, Wernicke JF. A comparison of fluoxetine, imipramine, and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989; 4: 313-322. Go to original source... Go to PubMed...
    16. Cole DP, Thase ME, Ferrlet IN, Eccleston D. Patterns of treatment resistance in bipolar affective disorder. Acta Psychiatr Scand 1993; 88: 121-123. Go to original source... Go to PubMed...
    17. Crawford P. Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs 2002; 16: 263-272. Go to original source... Go to PubMed...
    18. Crill WE. Neurobiological general principles related to epilepsy: neuronal mechanisms of seizure initiation. In: Glazer GH, Penry JL, Woodbury DM (eds): Antiepileptic Mechanisms of Action. New York, Raven Press 1980.
    19. Daly K a Fasemi S. Lamotrigine and impulse behavior. Can J Psychiatry 1999; 44: 395-396. Go to PubMed...
    20. Davanzo P a King B. Open trial of lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. J Child Adolesc Psychopharmacology 1996; 6: 273-279. Go to original source... Go to PubMed...
    21. Devarajan S a Dursum S. Aggression in dementia with lamotrigine treatment (letter) Am J Psychiatry 2000; 157: 1178. Go to original source... Go to PubMed...
    22. Dunner DL a Fieve RR. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30: 229-233. Go to original source... Go to PubMed...
    23. Erfurth A, Walden J, Grunze H. Lamotrigine in the treatment of schizoaffective disorder. Neuropsychobiology 1998; 38: 204-205. Go to original source... Go to PubMed...
    24. Finch D, Fisher R. Jackson M. Miniature excitatory synaptic currents in cultured hippocampal neurons. Brain Res 1990; 518: 257-258. Go to original source... Go to PubMed...
    25. Ferveza FC, Kanakiriya S, Kunau RT et al.: Acute granulomatous interstitial nephritis and colitis in anticonvulsant hypersensitivity syndrom associated with lamotrigine treatment. Am J Kidney Dis 2000; 36: 1034-1040. Go to original source... Go to PubMed...
    26. Frye M, Ketter T, Kimbrell T et al.: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorder. J Clin Psychopharmacol 2000; 20: 607-614. Go to original source... Go to PubMed...
    27. Goa KL, Ross SR, Chrisp P. Lamotrigine. A review of its pharmacological and clinical efficacy in epilepsy. Drugs 1993; 46: 152-176. Go to original source... Go to PubMed...
    28. Graham S Chen J, Leach M et al.: BW619C89 decreases glutamate release and infarction volume after MCA occlusion in the rat (abstract) Can J Neurol Sci 1993; 20 (suppl 4): S138.
    29. Green B. Lamotrigine in mood disorder. Curr Med Res Opin 2003; 19: 272-277. Go to original source... Go to PubMed...
    30. Grinage BD. Diagnosis and management of post-traumatic stress disorder. Am Fam Phys 2003; 68: 2401-2409.
    31. Grof P: Selecting effective long-term treatment for bipolar patients. Monotherapy and combinations. J Clin Psychiatry 2003; 64 (suppl 5): 53-61.
    32. Grunze H, Greene R, Moller H et al.: Lamotrigine may limit pathological excitation in the hippocampus by modulating a transient potassium outward current. Brain Res 1998; 791: 330-334. Go to original source... Go to PubMed...
    33. Guberman A, Besag F, Brondie M et al.: Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 1999; 40: 985-991. Go to original source... Go to PubMed...
    34. Harrison N a Simonds M. Quantitative studies on some antagonists of N-methyl-D-aspartate in slices of rat cerebral cortex. Br J Pharmacol 1985; 84: 381-391. Go to original source... Go to PubMed...
    35. Herman E: Lamotrigine. A depression modd stabiliser. Eur Neuropsychopharmacol 2004; 14 (suppl 2): S89-S93. Go to original source... Go to PubMed...
    36. Herman E, Hovorka J, Syrovatka J, Nemcova I. Lamotrigine as the mood stabiliser in the treatment of patients with bipolar disorder II. Ceska a Slovenska Psychiatrie 2002; 98: 8-14.
    37. Hertzberg M, Butterfiel M, Feldman et al.: A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 1999; 45: 1226-1229. Go to original source... Go to PubMed...
    38. Himmelhoch JM, Thase ME, Mallinger AG, Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991; 148: 910-916. Go to original source... Go to PubMed...
    39. Ichim L, Berk M, Brook S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 2000; 12: 5-10. Go to original source...
    40. Jawad S, Richens A, Goodwin G et al.: Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989; 30: 656-663. Go to original source... Go to PubMed...
    41. Kossen M, Selten J, Kahn R. Elevated clozapine plasma levels with lamotrigine (letter) Am J Psychiatry 2001; 158: 1930. Go to original source... Go to PubMed...
    42. Koukopulos et al. 2003.
    43. Lamictal (package insert) Physicians Desk Reference 56th Edition. Montvale, NJ, Medical Economics Company, 2002; 1573.
    44. Leach JP, Brodie MJ. Lamotrigine. Clinical use. In: Levy RH, Mattson RH, Meldrum BS (eds): Aniepileptic Drugs. New York, Raven Press 1995; 889-895.
    45. Leach MJ, Lees G, Riddall DR. Lamotrigine. Mechanism of action. In: Levy RH, Mattson RH, Meldrum BS (eds): Aniepileptic Drugs. New York, Raven Press 1995; 861-869.
    46. Lee R a Coccaro E. Psychopharmacologic treatment in borderline personality disorder. Econ Neurosci 2001; 3: 63-69.
    47. Levy RH, Mattson RH, Meldrum BS. Antiepileptic drugs. 4th Edition. New York, Raven Press 1995.
    48. Lombroso C. Lamotrigine-induced tourettism. Neurology 1999; 52: 1191-1194. Go to original source... Go to PubMed...
    49. MacDonald RL a Kelly KM. Antiepileptic drug mechanism of action. Epilepsia 1995; 36 (suppl 2): 2-12. Go to original source... Go to PubMed...
    50. Mackay FJ, Witton LV, Pearce GL, Freemantle SN, Mann RD: Safety of long - term lamotrigine in epilepsy. Epilepsia 1997; 38: 881-886. Go to original source... Go to PubMed...
    51. Margolin A, Avants A, DePhilippis D et al.: A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients. Am J Drug Alcohol Abuse 1998; 24: 85-101. Go to original source... Go to PubMed...
    52. Messenheimer JA, Mullens EL, Giorgi L et al.: Safety review of adult clinical trial experience with lamotrigine. Drug Saf 1998; 18: 281-296. Go to original source... Go to PubMed...
    53. Mewasingh L, Aylett S, Kirkham F et al.: Hyponatraemia associated with lamotrigine in cranial diabetes insipidus (letter) Lancet 2000; 356: 656. Go to original source... Go to PubMed...
    54. Miller AA, Wheatley P, Sawyer DA et al.: Pharmacological studies on lamotrigine, a novel antiepileptic drug: anticonvulsant profile in mice and rats. Epilepsia 1986; 27: 483-489. Go to original source... Go to PubMed...
    55. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressans. Br J Psychiatry 1994; 164: 549-550. Go to original source... Go to PubMed...
    56. Petrie R, Reid I, Stewart C. The N-methyl-D-aspartate receptors, synaptic plasticity and depressive disorder: a critical review. Pharmacol Ther 2000; 87: 11-25. Go to original source... Go to PubMed...
    57. Pinto O a Akiskal H. Lamotrigine as a promising approach to borderline personality: an open case series without DSM-IV major mood disorder. J Affect Disord 1998; 51: 333-343. Go to original source... Go to PubMed...
    58. Post R, Weiss S, Pert A. Differential effects of carbamazepine and lithium on sensitization and kindling. Prog Neuropsychopharmacol Biol Psychiatry 1984; 8: 425-434. Go to original source... Go to PubMed...
    59. Post RM, Frye MA, Denicoff KD, Kimbrell TA, Dunn RT, Leverich GS. Alternative treatment for refractory mania/rapid cycling (abstract), In: APA Annual Meeting, Toronto, Proceedings Summary 1998; 287.
    60. Preston GA, Marchant BK, Reimherr FW, Strong RE, Hedges DW. Borderline personality disorder in patients with bipolar disorder and response to lamotrigine. J Affective Disord 2004; 79: 297-303. Go to original source... Go to PubMed...
    61. Rizvi ST. Lamotrigine and borderline personality disorder. J Child Adoles Psychopharmacol 2002; 12: 365-366. Go to original source... Go to PubMed...
    62. Saba G, Dumortier G, Kalalou K et al.: Lamotrigine-clozapine combination in refractory schizophrenia: three cases (letter). J Neuropsychiatry Clin Neurosci 2002; 14 (1): 86. Go to original source... Go to PubMed...
    63. Sabers A, Buchholt J, Uldall P et al.: Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res 2001; 47: 151-154. Go to original source... Go to PubMed...
    64. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder. Postrad Med Special Issue 2000; 1: 1-104.
    65. Sarzi-Puttini P, Panni B, Cazzola M et al.: Lamotrigine-induced lupus. Lupus 2000; 9: 5555572000. Go to original source... Go to PubMed...
    66. Sasson Y, Chopra M, Harrari E, Amitai K, Zohar J. Bipolar comorbidity: From diagnostic dilemmas to therapeutic challenge. Int J Neuropsychopharmacol. 2003; 6: 139-144. Go to original source... Go to PubMed...
    67. Sbej M a Campellone. Stupor from lamotrigine toxicity. Epilepsia 2001; 42: 1082-1083. Go to original source... Go to PubMed...
    68. Schachter S, Leppik E, Matsuo F et al.: Lamotrigine: a 6-month, placebo-controlled, safety and tolerance study. J Epilepsy 1995; 8: 201-209. Go to original source...
    69. Showalter P a Kimmel D. Stimulation of consciousness and cognition after severe brain injury. Brain Inj 2000; 14: 99-1001.
    70. Sierra M, Phillips M, Lambert M et al.: Lamotrigine in the treatment of depersonalization disorder. J Clin Psychiatry 2000; 62: 826-827. Go to original source... Go to PubMed...
    71. Sierra M, Phillips ML, Ivin G, Krystal J, David AS. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. J Psychopharmacol 2003; 17: 103-105. Go to original source... Go to PubMed...
    72. Smith D, Chadwick D, Baker G et al.: Seizure severity and the quality of life. Epilepsia 1993; 34 (suppl 5): S31-S35. Go to original source... Go to PubMed...
    73. Stefani A, Spadoni F, Sinischali A et al.: Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. Eur J Pharmacol 1996; 307: 113-116. Go to original source... Go to PubMed...
    74. Stenbom Y, Tonnby B, Hagberg B. Lamotrigine in Rett syndrome: treatment experience from a pilot study. Eur Child Adolesc Psychiatry 1998; 7: 49-52. Go to original source... Go to PubMed...
    75. Sullivan JR a Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Ann Dermatol 2001; 137: 357-364.
    76. Švestka J. Nová psychofarmaka: Antiepileptika III. generace a jejich použití v psychiatrii. Psychiatrie 1998; 2: 250-262.
    77. Tavernor S, Wong I, Newton R et al.: Rechallenge with lamotrigine after initial resh. Seizure 1995; 4: 67-71. Go to original source... Go to PubMed...
    78. Tekin S, Aykut-Bingol C, Tanridag T et al.: Antiglutametergic therapy in Alzheimer's diseaseeffects of lamotrigine. J Neural Transm 1998; 105: 295-303. Go to original source... Go to PubMed...
    79. Yau M, Wargin W, Wolf K et al.: Effect of valproate on the pharmacokinetics of lamotrigine at steady state (abstract) Epilepsia 1992; 33 (suppl 3): 82.

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.